Date: October 01, 2026
Board Meeting Outcomes
- The company has received listing approval from both National Stock Exchange of India Limited (NSE) and BSE Limited for 13,73,625 fully paid-up Equity Shares allotted on a preferential basis.
- The approval was granted on October 01, 2026, with NSE reference number NSE/LIST/57509 and BSE reference number LOD/PREF/DD/FIP/875/2026-27.
Fundraising / Financing
- Number of Shares: 13,73,625 (Thirteen Lakhs Seventy Three Thousand Six Hundred Twenty Five) equity shares
- Face Value: ₹10 per share
- Issue Price: ₹2,002 per share (including a premium of ₹1,992 per share)
- Allotment Type: Preferential basis for cash
- Distinctive Numbers: 15713841 to 17087465
- Allottee Category: Non-promoters
Regulatory Compliance Requirements
- The company must ensure compliance with Regulation 167 of SEBI (ICDR) Regulations
- For any change exceeding two percent of total paid-up share capital, the company shall file shareholding pattern in XBRL mode as required under Regulations 31(1)(c) of SEBI LODR Regulations, 2015
- Trading approval will be granted only after:
- Submission of listing approval from NSE (if applicable)
- Confirmation letters from NSDL/CDSL about crediting shares to beneficiary accounts
- Confirmation letters from NSDL/CDSL about lock-in of pre-preferential holding (if applicable)
- The company must apply for trading approval within seven working days from the date of grant of listing approval as per SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023